Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Benazin is indicated for the treatment of chorea associated with Huntington's disease.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Tetrabenazine was originally developed as an antipsychotic, but today it is mainly used to relieve symptoms of various hyperkinetic movement disorders. It works as a vesicular monoamine transporter-2 (VMAT-2) inhibitor and is used specifically to treat chorea associated with Huntington's disease.

Pregnancy & Breastfeeding

Pregnancy: There isn't enough evidence to know whether Tetrabenazine poses a developmental risk if taken during pregnancy.

Breastfeeding: It isn't known whether Tetrabenazine or its breakdown products pass into breast milk.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: You can take Tetrabenazine with or without food. The dose has to be set for each patient, with careful weekly titration. In the 1st week the starting dose is 12.5 mg daily. In the 2nd week it goes up to 25 mg, given as 12.5 mg twice daily. After that, increase slowly at weekly intervals by 12.5 mg, until you reach a dose the patient tolerates that reduces chorea. Doses of 37.5 mg and up to 50 mg per day should be given in three divided doses, and no single dose should be more than 25 mg. Patients who need more than 50 mg per day should be genotyped for the drug-metabolizing enzyme CYP2D6, to find out whether they are poor metabolizers or extensive metabolizers. In poor metabolizers the maximum daily dose is 50 mg, with a maximum single dose of 25 mg. In extensive and intermediate metabolizers the maximum daily dose is 100 mg, with a maximum single dose of 37.5 mg. If serious adverse reactions occur, stop the titration and lower the dose. If the adverse reactions don't resolve, consider withdrawing Tetrabenazine. Pediatric and geriatric use: safety and effectiveness in pediatric patients have not been established. The pharmacokinetics of Tetrabenazine and its primary metabolites have not been formally studied in geriatric subjects.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →